{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:47:04Z","timestamp":1764701224315,"version":"3.44.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.amjms.2025.07.002","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T07:50:37Z","timestamp":1752565837000},"page":"405-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intranasal administration of stem cell therapy: A promising approach for early Alzheimer\u2019s disease intervention"],"prefix":"10.1016","volume":"370","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7103-9364","authenticated-orcid":false,"given":"Eeshal","family":"Fatima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7103-2036","authenticated-orcid":false,"given":"Anoushey","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjms.2025.07.002_bib0001","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14283\/jpad.2021.15","article-title":"The epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J Prevent Alzheimer\u2019s Dis"},{"key":"10.1016\/j.amjms.2025.07.002_bib0002","article-title":"Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets","volume":"13","author":"Cai","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjms.2025.07.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115522","article-title":"Alzheimer\u2019s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs","volume":"211","author":"Monteiro","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.amjms.2025.07.002_bib0004","unstructured":"New biomarker tracks cognitive decline in Alzheimer\u2019s disease [Internet]. National Institutes of Health (NIH). 2025 Accessed on 2025 May 2. Available from: https:\/\/www.nih.gov\/news-events\/nih-research-matters\/new-biomarker-tracks-cognitive-decline-alzheimer-s-disease."},{"key":"10.1016\/j.amjms.2025.07.002_bib0005","first-page":"1","article-title":"A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer\u2019s disease","author":"Oh","year":"2025","journal-title":"Nature Med"},{"issue":"11","key":"10.1016\/j.amjms.2025.07.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12519","article-title":"Extracellular vesicles from human-induced pluripotent stem cell-derived neural stem cells alleviate proinflammatory cascades within disease-associated microglia in Alzheimer\u2019s disease","volume":"13","author":"Madhu","year":"2024","journal-title":"J Extracellul Vesicles"},{"key":"10.1016\/j.amjms.2025.07.002_bib0007","unstructured":"How is Alzheimer\u2019s disease treated? [Internet]. National Institute on Aging. 2023 Accessed on 2025 May 2. Available from: https:\/\/www.nia.nih.gov\/health\/alzheimers-treatment\/how-alzheimers-disease-treated."},{"issue":"5","key":"10.1016\/j.amjms.2025.07.002_bib0008","article-title":"Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer\u2019s disease","volume":"32","author":"Imam","year":"2024","journal-title":"Saudi Pharmaceut J"},{"issue":"3","key":"10.1016\/j.amjms.2025.07.002_bib0009","doi-asserted-by":"crossref","first-page":"459","DOI":"10.9758\/cpn.2021.19.3.459","article-title":"Real-world evaluation of tolerability, safety and efficacy of Rivastigmine oral solution in patients with mild to moderate Alzheimer\u2019s disease dementia","volume":"19","author":"Hsieh","year":"2021","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.amjms.2025.07.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123809","article-title":"Rivastigmine nasal spray for the treatment of Alzheimer\u2019s Disease: olfactory deposition and brain delivery","volume":"652","author":"Guo","year":"2024","journal-title":"Int J Pharmaceut"},{"issue":"5","key":"10.1016\/j.amjms.2025.07.002_bib0011","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3390\/pharmaceutics15051399","article-title":"Intranasal drug administration in Alzheimer-type dementia: towards clinical applications","volume":"15","author":"Tal\u00e9ns-Visconti","year":"2023","journal-title":"Pharmaceutics"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925010997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925010997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:43:02Z","timestamp":1758048182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925010997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0002962925010997"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.07.002","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal administration of stem cell therapy: A promising approach for early Alzheimer\u2019s disease intervention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}